India, Aug. 5 -- While reporting financial results for the second quarter, drug major Pfizer, Inc. (PFE) raised its adjusted earnings guidance for the full-year 2025, while reaffirming revenue outlook.
For fiscal 2025, the company now projects adjusted earnings in a range of $2.90 to $3.10 per share, up from the prior forecast of $2.80 to $3.00 per share. The company reaffirms its revenue guidance between $61.0 billion and $64.0 billion.
On average, 23 analysts polled expect the company to report earnings of $3.01 per share on revenues of $62.67 billion for the year. Analysts' estimates typically exclude special items.
The guidance is driven by strong year-to-date performance, continued confidence in its business, a favorable impact from...